União Europeia - português - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - istradefylline - doença de parkinson - anti-parkinson - istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with parkinson’s disease (pd) experiencing “off” time.